Tenosynovial Giant Cell Tumor, Diffuse Type

Tenosynovial Giant Cell Tumor, Diffuse Type — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03069469	Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor	active not recruiting	Phase 1 / Phase 2	120	Deciphera Pharmaceuticals, LLCINDUSTRY	9	Jun 25, 2026	clinicaltrials
NCT02471716	Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor(FPA008-002)	completed	Phase 1 / Phase 2	66	Five Prime Therapeutics, Inc.INDUSTRY	6	Aug 31, 2021	clinicaltrials
NCT02673736	A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor	terminated	Phase 1	11	PlexxikonINDUSTRY	1	Aug 2, 2018	clinicaltrials

Data updated 23 days agoSource updated Jun 25, 2026source: clinicaltrials